Which specific side effects of lurbinectedin caused treatment delays?

Which side effects were linked to lurbinectedin treatment delays?

In the provided material, the specific side effects that caused treatment delays for lurbinectedin are described as “hematologic and non-hematologic toxicities,” but the text does not list which exact adverse events (e.g., specific lab abnormalities or symptoms) were responsible for the delays. [1]

Does the record name the exact toxicities (e.g., neutropenia, anemia, fatigue)?

No. The available excerpt groups the cause of delays into two broad categories—hematologic toxicities and non-hematologic toxicities—without naming particular side effects. [1]

Where treatment delays fit into the safety picture for lurbinectedin

The same excerpt frames these toxicities as part of the safety findings for lurbinectedin, with treatment delays occurring in association with those hematologic and non-hematologic effects. [1]

Can I identify the specific side effects by looking up the full safety section?

To identify the exact side effects that led to delays, you would need the full safety/results text (often the “Dose modifications,” “Treatment delays,” or “Adverse events” subsection) from the source document. The excerpt available here does not include that level of detail. [1]

Source

1. https://www.drugs.com/newdrugs/lurbinectedin.html